Laura Andrews

Preclinical development of monoclonal antibodies

Kathryn Chapman, Nick Pullen, Lee Coney et al. · mAbs · 2009 · 97 citations · Full text

Pharmacy, Immunology, Pharmaceutical Biotechnology +17

Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe disease

Alison McVie‐Wylie, K.L. Lee, Hengheng Qiu et al. · Molecular Genetics and Metabolism · 2008 · 96 citations · Full text

Life Sciences, Biochemistry, Pharmacotherapy +7

The design of chronic toxicology studies of monoclonal antibodies: Implications for the reduction in use of non-human primates

Kathryn Chapman, Laura Andrews, Jeffrey J. Bajramović et al. · Regulatory Toxicology and Pharmacology · 2011 · 67 citations

Pharmacy, Pharmacology, Toxicology +9

The use of alternative therapies by children with asthma: A brief report

Laura Andrews, S LOKUGE, Michael Sawyer et al. · Journal of Paediatrics and Child Health · 1998 · 65 citations

Public Health, Child Health, Pediatrics +9

Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics

James Murray, Anne Marie Thompson, Allison Vitsky et al. · Molecular Genetics and Metabolism · 2014 · 53 citations · Full text

Veterinary Medicine, Pharmacology, Toxicology +17